null

Trastuzumab (Anti-Her2) Biosimilar Antibody

SKU:
HDBS0047
Product Type:
Biosimilar Antibody
Antibody Type:
Monoclonal Antibody
Protein:
HER-2
Reactivity:
Human
Host Species:
Humanized
Isotype:
IgG1
€373
Frequently bought together:

Description

system_update_altDatasheet

Trastuzumab (Anti-Her2) Biosimilar Antibody (HDBS0047)

The ERBB2 Biosimilar Monoclonal Antibody (HDBS0047) is a cutting-edge tool for researchers studying ERBB2, a key protein involved in cancer development and progression. This antibody, produced through advanced biotechnological processes, specifically targets ERBB2 and has been rigorously tested for effectiveness in various experimental applications.ERBB2, also known as HER2, is a receptor tyrosine kinase that is overexpressed in a variety of cancer types, including breast and gastric cancer. Targeting ERBB2 with monoclonal antibodies has revolutionized the treatment of HER2-positive cancers, leading to significant improvements in patient outcomes.The ERBB2 Biosimilar Monoclonal Antibody (HDBS0047) offers researchers a reliable tool for studying the role of ERBB2 in cancer biology and developing novel therapeutic strategies.

Its high specificity and sensitivity make it an essential reagent for immunoassays, immunohistochemistry, and other experimental techniques aimed at elucidating the mechanisms underlying ERBB2-mediated tumorigenesis.By using the ERBB2 Biosimilar Monoclonal Antibody (HDBS0047), researchers can gain valuable insights into the molecular pathways regulated by ERBB2 and identify new targets for the development of targeted cancer therapies. This antibody is a valuable asset for scientists working in the fields of oncology, molecular biology, and drug discovery, offering unparalleled precision and reliability in their research endeavors.